MicroRNA-125b potentiates macrophage activation

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5062-5068

  Chaudhuri, Aadel A ^a   So, Alex Yick Lun ^a   Sinha, Nikita ^a   Gibson, William S J ^a   Taganov, Konstantin D ^b   O'Connell, Ryan M ^c   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b REGULUS THERAPEUTICS   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; MICRORNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR CELL DESTRUCTION;

ANIMALS; ANTIGEN PRESENTATION; BASE SEQUENCE; BONE MARROW CELLS; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOTOXICITY TESTS, IMMUNOLOGIC; HEK293 CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MOLECULAR SEQUENCE DATA; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 81455141958     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102001     Document Type: Article

References (35)

1. Murphy, K. P., P. Travers, M. Walport, and C. Janeway. 2008. Janeway's Immunobiology. Garland Science, New York.
2. Kindt, T. J., R. A. Goldsby, B. A. Osborne, and J. Kuby. 2007. Kuby Immunology. W.H. Freeman, New York.
3. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122.
4. O'Neill, L. A., F. J. Sheedy, and C. E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11: 163-175.
5. Androulidaki, A., D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis, and C. Tsatsanis. 2009. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
6. Tili, E., J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin, and C. M. Croce. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179: 5082-5089.
7. Murphy, A. J., P. M. Guyre, and P. A. Pioli. 2010. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J. Immunol. 184: 5029-5037.
8. O'Connell, R. M., A. A. Chaudhuri, D. S. Rao, W. S. Gibson, A. B. Balazs, and D. Baltimore. 2010. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc. Natl. Acad. Sci. USA 107: 14235-14240.
9. Ooi, A. G., D. Sahoo, M. Adorno, Y. Wang, I. L. Weissman, and C. Y. Park. 2010. MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc. Natl. Acad. Sci. USA 107: 21505-21510.
10. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, M. P. Boldin, K. D. Taganov, J. Nicoll, R. L. Paquette, and D. Baltimore. 2008. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205: 585-594. (Pubitemid 351439306)
11. O'Connell, R. M., A. A. Chaudhuri, D. S. Rao, and D. Baltimore. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106: 7113-7118.
12. Rao, D. S., R. M. O'Connell, A. A. Chaudhuri, Y. Garcia-Flores, T. L. Geiger, and D. Baltimore. 2010. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 33: 48-59.
13. Davis, S., S. Propp, S. M. Freier, L. E. Jones, M. J. Serra, G. Kinberger, B. Bhat, E. E. Swayze, C. F. Bennett, and C. Esau. 2009. Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res. 37: 70-77.
14. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
15. Grimson, A., K. K. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27: 91-105. (Pubitemid 46991392)
16. Friedman, R. C., K. K. Farh, C. B. Burge, and D. P. Bartel. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19: 92-105.
17. Zhou, R., G. Hu, A. Y. Gong, and X. M. Chen. 2010. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res. 38: 3222-3232.
18. Yang, L., and D. Baltimore. 2005. Long-term in vivo provision of antigenspecific T cell immunity by programming hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 102: 4518-4523. (Pubitemid 40397144)
19. Gururajan, M., C. L. Haga, S. Das, C. M. Leu, D. Hodson, S. Josson, M. Turner, and M. D. Cooper. 2010. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int. Immunol. 22: 583-592.
20. Negishi, H., Y. Ohba, H. Yanai, A. Takaoka, K. Honma, K. Yui, T. Matsuyama, T. Taniguchi, and K. Honda. 2005. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 102: 15989-15994. (Pubitemid 41552855)
21. Honma, K., H. Udono, T. Kohno, K. Yamamoto, A. Ogawa, T. Takemori, A. Kumatori, S. Suzuki, T. Matsuyama, and K. Yui. 2005. Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. Proc. Natl. Acad. Sci. USA 102: 16001-16006. (Pubitemid 41552857)
22. Malumbres, R., K. A. Sarosiek, E. Cubedo, J.W. Ruiz, X. Jiang, R. D. Gascoyne, R. Tibshirani, and I. S. Lossos. 2009. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
23. Wang, L., N. L. Toomey, L. A. Diaz, G. Walker, J. C. Ramos, G. N. Barber, and S. Ning. 2011. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression. J. Virol. 85: 8328-8337.
24. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
25. Bousquet, M., M. H. Harris, B. Zhou, and H. F. Lodish. 2010. MicroRNA miR- 125b causes leukemia. Proc. Natl. Acad. Sci. USA 107: 21558-21563.
26. Bousquet, M., C. Quelen, R. Rosati, V. Mansat-De Mas, R. La Starza, C. Bastard, E. Lippert, P. Talmant, M. Lafage-Pochitaloff, D. Leroux, et al. 2008. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J. Exp. Med. 205: 2499-2506.
27. Klusmann, J. H., Z. Li, K. Böhmer, A. Maroz, M. L. Koch, S. Emmrich, F. J. Godinho, S. H. Orkin, and D. Reinhardt. 2010. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev. 24: 478-490.
28. Gefen, N., V. Binder, M. Zaliova, Y. Linka, M. Morrow, A. Novosel, L. Edry, L. Hertzberg, N. Shomron, O. Williams, et al. 2010. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 24: 89-96.
29. Iorio, M. V., M. Ferracin, C. G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, et al. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65: 7065-7070. (Pubitemid 41161233)
30. Ozen, M., C. J. Creighton, M. Ozdemir, and M. Ittmann. 2008. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793. (Pubitemid 351380263)
31. Yang, H., W. Kong, L. He, J. J. Zhao, J. D. O'Donnell, J. Wang, R. M. Wenham, D. Coppola, P. A. Kruk, S. V. Nicosia, and J. Q. Cheng. 2008. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68: 425-433. (Pubitemid 351380068)
32. Guan, Y., H. Yao, Z. Zheng, G. Qiu, and K. Sun. 2011. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Int. J. Cancer 128: 2274-2283.
33. Glud, M., M. Rossing, C. Hother, L. Holst, N. Hastrup, F. C. Nielsen, R. Gniadecki, and K. T. Drzewiecki. 2010. Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma Res. 20: 479-484.
34. Henson, B. J., S. Bhattacharjee, D. M. O'Dee, E. Feingold, and S. M. Gollin. 2009. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582.
35. Wong, T. S., X. B. Liu, B. Y. Wong, R. W. Ng, A. P. Yuen, and W. I. Wei. 2008. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin. Cancer Res. 14: 2588-2592.